ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,392,555 | -25.4% | 132,781 | -16.2% | 0.02% | -23.1% |
| Q2 2023 | $4,545,350 | -8.2% | 158,485 | -23.2% | 0.03% | -23.5% |
| Q1 2023 | $4,949,182 | +39.5% | 206,474 | -1.3% | 0.03% | +13.3% |
| Q4 2022 | $3,548,948 | -8.2% | 209,254 | -19.8% | 0.03% | -26.8% |
| Q3 2022 | $3,868,000 | +22.8% | 260,980 | +30.4% | 0.04% | +41.4% |
| Q2 2022 | $3,151,000 | -61.3% | 200,186 | -33.8% | 0.03% | -39.6% |
| Q1 2022 | $8,147,000 | -0.1% | 302,190 | +37.1% | 0.05% | +11.6% |
| Q4 2021 | $8,157,000 | +7.5% | 220,406 | +38.7% | 0.04% | -17.3% |
| Q3 2021 | $7,591,000 | +20.1% | 158,883 | -15.0% | 0.05% | +30.0% |
| Q2 2021 | $6,322,000 | +127.3% | 186,829 | +177.4% | 0.04% | +110.5% |
| Q1 2021 | $2,781,000 | +628.0% | 67,346 | +665.7% | 0.02% | +375.0% |
| Q4 2020 | $382,000 | -82.7% | 8,795 | -82.9% | 0.00% | -85.2% |
| Q3 2020 | $2,205,000 | – | 51,404 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
| DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
| HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
| Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
| Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
| ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
| Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
| COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
| Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
| HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |